Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

Not Applicable

Withdrawn

• Conditions: Persistent Pulmonary Hypertension; Respiratory Distress Syndrome

• Registration Number: NCT00216931
• Lead Sponsor: Lund University Hospital

Brief Summary

The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2005-09-15
• Study First Submitted QC: 2005-09-15
• Study First Posted: 2005-09-22
• Study Start: 2006-05
• Study Completion: 2008-10
• Status Verified: 2009-02
• Last Update Submitted: 2009-02-03
• Last Update Posted: 2009-02-04

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Elevated arterial pulmonary pressure
• GA > 24 GW
• 24-48 hours of age
• Ventilator treatment

Exclusion Criteria

• Congenital anomalies
• Severe hypotension

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Oxygenation index
Cardiac output

Trial Locations

Locations (1)

University Hospital in Lund , Department of Pediatrics; 🇸🇪 Lund, Sweden